Detalhe da pesquisa
1.
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Blood
; 140(23): 2500-2513, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984904
2.
CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Acta Neuropathol Commun
; 12(1): 12, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243303
3.
Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy.
Bull Cancer
; 108(10S): S92-S95, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34920812
4.
Drug-drug interaction and inadequate exposure to voriconazole in critically ill patients with multiple organ failure: A pediatric case study.
Therapie
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729827
5.
Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group.
Leukemia
; 37(8): 1723-1726, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328541